Author

Daniel J. O'Connor

Observed names: Dan O’Connor, O'Connor, Dan

Institution: Association of the British Pharmaceutical Industry

Observed institution: Association of the British Pharmaceutical Industry

OpenAlex ID: A5141209527

A scalable and equitable framework for target and patient prioritisation in rare disease antisense therapeutics

2026 · Ella F. Whittle, Kylie-Ann Montgomery, et al. · medRxiv · 1

UK Regulatory and Access Frameworks in Rare Disease. Current status, opportunities and challenges. Workshop report

2026 · Hedley, Vicki, O'Connor, Dan, et al. · Research Portal (Queen's University Belfast)

Beyond data and technology: the need for new thinking to enable the era of precision prevention

2026 · Maria Tsakiroglou, Pradeep Harish, et al. · BMC Medicine

Works count: 3

Citation count: 1

H-index: 1

I10-index: